STOCKWATCH
·
Pharmaceuticals
Acquisitions30 Sept 2025, 04:41 pm

Zydus Lifesciences Extends Closing Date of API Business Acquisition from Sterling Biotech to December 31, 2025

AI Summary

Zydus Lifesciences Limited has informed that the company and Sterling Biotech Limited have executed a letter to extend the closing date of the acquisition of Sterling Biotech's API business by Zydus Lifesciences. The new closing date is on or before December 31, 2025. This extension is due to Sterling Biotech being in the process of completing certain conditions precedents of the Business Transfer Agreement.

Key Highlights

  • Zydus Lifesciences and Sterling Biotech extend the closing date of API business acquisition to December 31, 2025
  • Extension is due to Sterling Biotech completing certain conditions precedents of the Business Transfer Agreement
  • The acquisition is expected to boost Zydus Lifesciences' API business portfolio
ZYDUSLIFE
Pharmaceuticals
Zydus Lifesciences Ltd

Price Impact